Sookjin Lee

Chief Business Officer (CBO) | Ph.D.

A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.

Unlocking the “Unmappable” D4Z4 Repeat: How 3billion Mastered FSHD Diagnosis with Long-Read Sequencing2026. 10. 07
Mitochondrial Disease Doesn’t Arrive Looking Typical2026. 09. 15
[On the Road to Meet] “Designing the System Together as True Partners” — Changdeok Ji, Rare Disease Business Architect (Part 2)2026. 08. 26
[On the Road to Meet] “Expanding the Market to Speed Up Diagnosis” — Changdeok Ji, Rare Disease Business Architect (Part 1)2026. 08. 26
Sudden Death in Healthy Adults: Why a “Normal” Genetic Test Doesn’t Mean You’re Safe from Brugada Syndrome2026. 08. 14
VUS Reanalysis: What Actually Changes, and Who Can Change It2026. 08. 03